NCT05312567 - FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

April 5, 2023

Study Completion Date

July 31, 2023

Conditions

Vasomotor SymptomsMenopause

Interventions

DRUG

FP-101

daily oral tablet administration (b.i.d.)

Trial Locations (12)

Clinical Research of Philadelphia, Philadelphia

Cary Medical Group, Cary

Raleigh Medical Group, Raleigh

Coastal Carolina Research Center, North Charleston

Inpatient Research Clinic, Hialeah

The Angel Medical Research Corporation, Miami Lakes

Suncoast Clinical Research - Pasco County, New Port Richey

ICON Early Phase Services, San Antonio

Discovery Clinical Trials - Stone Oak, San Antonio

Torrance Clinical Research Institute, Lomita

Long Beach Clinical Trial Services, Long Beach

Provideré Research Inc., West Covina